ArQule

ArQule is a biopharmaceutical company engaged in the research and development of targeted therapies for cancer and rare diseases. ArQule's mission is to discover, develop, and commercialize novel small-molecule drugs in areas of high unmet need, which will significantly extend and improve the lives of our patients. Our clinical-stage pipeline consists of five drug candidates, all of which are targeted toward biomarker-defined patient populations, establishing ArQule as a leader in precision medicine.